Prevalence, incidence and persistence of ADHD drug use in Japan

Epidemiol Psychiatr Sci. 2019 Dec;28(6):692-696. doi: 10.1017/S2045796018000252. Epub 2018 May 28.

Y Okumura^{1

2}, M Usami³, T Okada⁴, T Saito⁵, H Negoro⁶, N Tsujii⁷, J Fujita⁸, J Iida⁹

¹ Research Department, Institute for Health Economics and Policy, Association for Health Economics Research and Social Insurance and Welfare, Tokyo, Japan.
² Department of Psychiatry and Behavioral Science, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
³ Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Chiba, Japan.
⁴ Department of Child and Adolescent Psychiatry, Nagoya University Graduate School of Medicine, Aichi, Japan.
⁵ Department of Child and Adolescent Psychiatry, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
⁶ Graduate School of Professional Development in Education, Nara University of Education, Nara, Japan.
⁷ Department of Neuropsychiatry, Kindai University Faculty of Medicine, Osaka, Japan.
⁸ Department of Child Psychiatry, Yokohama City University Hospital, Kanagawa, Japan.
⁹ Department of Human Development, Faculty of Nursing, Nara Medical University, Nara, Japan.

No abstract available

Keywords: ADHD; adolescent health; atomoxetine; methylphenidate; pharmacotherapy.

MeSH terms